These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 34905965)
21. COVID-19 in Germany and China: mitigation versus elimination strategy. Lu G; Razum O; Jahn A; Zhang Y; Sutton B; Sridhar D; Ariyoshi K; von Seidlein L; Müller O Glob Health Action; 2021 Jan; 14(1):1875601. PubMed ID: 33472568 [No Abstract] [Full Text] [Related]
22. In-flight transmission of wild-type SARS-CoV-2 and the outbreak potential of imported clusters of COVID-19: a review of published evidence. Kelly D; Bambury N; Boland M Global Health; 2021 Aug; 17(1):93. PubMed ID: 34419084 [TBL] [Abstract][Full Text] [Related]
23. Deciphering early-warning signals of SARS-CoV-2 elimination and resurgence from limited data at multiple scales. Parag KV; Cowling BJ; Donnelly CA J R Soc Interface; 2021 Dec; 18(185):20210569. PubMed ID: 34905965 [TBL] [Abstract][Full Text] [Related]
24. Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study. Lane CR; Sherry NL; Porter AF; Duchene S; Horan K; Andersson P; Wilmot M; Turner A; Dougall S; Johnson SA; Sait M; Gonçalves da Silva A; Ballard SA; Hoang T; Stinear TP; Caly L; Sintchenko V; Graham R; McMahon J; Smith D; Leong LE; Meumann EM; Cooley L; Schwessinger B; Rawlinson W; van Hal SJ; Stephens N; Catton M; Looker C; Crouch S; Sutton B; Alpren C; Williamson DA; Seemann T; Howden BP Lancet Public Health; 2021 Aug; 6(8):e547-e556. PubMed ID: 34252365 [TBL] [Abstract][Full Text] [Related]
25. Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia. Blakely T; Thompson J; Bablani L; Andersen P; Ait Ouakrim D; Carvalho N; Abraham P; Boujaoude MA; Katar A; Akpan E; Wilson N; Stevenson M JAMA Health Forum; 2021 Jul; 2(7):e211749. PubMed ID: 35977202 [TBL] [Abstract][Full Text] [Related]
26. Modelling SARS-CoV-2 disease progression in Australia and New Zealand: an account of an agent-based approach to support public health decision-making. Thompson J; McClure R; Blakely T; Wilson N; Baker MG; Wijnands JS; De Sa TH; Nice K; Cruz C; Stevenson M Aust N Z J Public Health; 2022 Jun; 46(3):292-303. PubMed ID: 35238437 [TBL] [Abstract][Full Text] [Related]
27. Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore. De Foo C; Grépin KA; Cook AR; Hsu LY; Bartos M; Singh S; Asgari N; Teo YY; Heymann DL; Legido-Quigley H Lancet; 2021 Oct; 398(10311):1547-1551. PubMed ID: 34619099 [No Abstract] [Full Text] [Related]
28. Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong. Gu H; Xie R; Adam DC; Tsui JL; Chu DK; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Cheng SSM; Edwards KM; Leung KSM; Wu JT; Tsang DNC; Leung GM; Cowling BJ; Peiris M; Lam TTY; Dhanasekaran V; Poon LLM Nat Commun; 2022 Feb; 13(1):736. PubMed ID: 35136039 [TBL] [Abstract][Full Text] [Related]
29. Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020. Smith MR; Trofimova M; Weber A; Duport Y; Kühnert D; von Kleist M Nat Commun; 2021 Oct; 12(1):6009. PubMed ID: 34650062 [TBL] [Abstract][Full Text] [Related]
30. Improved estimation of time-varying reproduction numbers at low case incidence and between epidemic waves. Parag KV PLoS Comput Biol; 2021 Sep; 17(9):e1009347. PubMed ID: 34492011 [TBL] [Abstract][Full Text] [Related]
32. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H; Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915 [TBL] [Abstract][Full Text] [Related]
33. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. du Plessis L; McCrone JT; Zarebski AE; Hill V; Ruis C; Gutierrez B; Raghwani J; Ashworth J; Colquhoun R; Connor TR; Faria NR; Jackson B; Loman NJ; O'Toole Á; Nicholls SM; Parag KV; Scher E; Vasylyeva TI; Volz EM; Watts A; Bogoch II; Khan K; ; Aanensen DM; Kraemer MUG; Rambaut A; Pybus OG Science; 2021 Feb; 371(6530):708-712. PubMed ID: 33419936 [TBL] [Abstract][Full Text] [Related]
34. An exact method for quantifying the reliability of end-of-epidemic declarations in real time. Parag KV; Donnelly CA; Jha R; Thompson RN PLoS Comput Biol; 2020 Nov; 16(11):e1008478. PubMed ID: 33253158 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study. Jefferies S; French N; Gilkison C; Graham G; Hope V; Marshall J; McElnay C; McNeill A; Muellner P; Paine S; Prasad N; Scott J; Sherwood J; Yang L; Priest P Lancet Public Health; 2020 Nov; 5(11):e612-e623. PubMed ID: 33065023 [TBL] [Abstract][Full Text] [Related]
37. Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Ali ST; Wang L; Lau EHY; Xu XK; Du Z; Wu Y; Leung GM; Cowling BJ Science; 2020 Aug; 369(6507):1106-1109. PubMed ID: 32694200 [TBL] [Abstract][Full Text] [Related]
38. Using information theory to optimise epidemic models for real-time prediction and estimation. Parag KV; Donnelly CA PLoS Comput Biol; 2020 Jul; 16(7):e1007990. PubMed ID: 32609732 [TBL] [Abstract][Full Text] [Related]
39. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Ganyani T; Kremer C; Chen D; Torneri A; Faes C; Wallinga J; Hens N Euro Surveill; 2020 Apr; 25(17):. PubMed ID: 32372755 [TBL] [Abstract][Full Text] [Related]
40. Adaptive Estimation for Epidemic Renewal and Phylogenetic Skyline Models. Parag KV; Donnelly CA Syst Biol; 2020 Nov; 69(6):1163-1179. PubMed ID: 32333789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]